Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Holcim Aktie 1221405 / CH0012214059

04.11.2025 14:50:03

Holcim wins EU funding for Romania clean tech project to produce near-zero cement

Holcim Group Services Ltd / Key word(s): Miscellaneous
Holcim wins EU funding for Romania clean tech project to produce near-zero cement

04.11.2025 / 14:50 CET/CEST


 
  • Campulung, Romania, will be Eastern Europe’s first full-scale onshore CCS project
  • Carbon Hub CPT 01 project will produce an estimated 2 million tons of near-zero cement per annum from 2032
  • Holcim now has eight large-scale EU-supported carbon capture projects

 

Holcim has been selected for a European Union Innovation Fund grant for its carbon capture and storage (CCS) project in Campulung, Romania, which will produce near-zero cement from 2032 and advance the EU’s Clean Industrial Deal.

 

As the first large-scale onshore CCS project of its kind in Eastern Europe, Carbon Hub CPT 01 marks a major milestone in the deployment of innovative low-carbon technologies in the region.

 

Simon Kronenberg, Region Head Central and East Europe: “Holcim’s CCS project in Romania will produce an estimated 2 million tons of near-zero cement per annum from 2032, supporting Holcim’s efforts to turn sustainable growth into profitable growth, a key strategic driver of its NextGen Growth 2030 strategy. This EU Innovation Fund support testifies to the strength of our engineering teams, the maturity of our technologies and our advanced partnerships that span the value chain.”

 

Carbon Hub CPT 01, which is being driven by an industrial consortium, will use proven carbon capture technology to separate CO2 from flue gases, which will then be compressed and transported for permanent, safe storage underground. A key partner for this project is Carmeuse, whose expertise is critical to building a robust CCS value chain.

 

Romania is well-positioned to benefit from this project thanks to its strong industrial base, favorable geology for CO2 storage and enabling policy environment. The project will drive sustainable innovation in the country and create high-quality jobs.

 

With this grant, Holcim now has eight large-scale EU-supported carbon capture, utilization and storage (CCUS) projects, the largest number of funded projects in the industry to date. These are located in Lägerdorf in Germany, Kujawy in Poland, Obourg in Belgium, Le Teil in France, Koromacno in Croatia, Milaki in Greece, Martres in France and Campulung in Romania. 

About Holcim
Holcim (SIX: HOLN) is the leading partner for sustainable construction with net sales of CHF 16.2 billion1 in 2024, creating value across the built environment from infrastructure and industry to buildings. Headquartered in Zug, Switzerland, Holcim has more than 45,000 employees in 44 attractive markets – across Europe, Latin America and Asia, Middle East & Africa. Holcim offers high-value end-to-end Building Materials and Building Solutions, from foundations and flooring to roofing and walling – powered by premium brands including ECOPlanet, ECOPact, and ECOCycle®.

1 Net sales 2024 restated following spin-off; excludes net sales to Amrize.

Learn more about Holcim on www.holcim.com, and by following us on LinkedIn.

Sign up for Holcim's Building Progress newsletter here.

Important disclaimer – forward-looking statements:
This document contains forward-looking statements. Such forward-looking statements do not constitute forecasts regarding results or any other performance indicator, but rather trends or targets, as the case may be, including with respect to plans, initiatives, events, products, solutions and services, their development and potential. Although Holcim believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions as at the time of publishing this document, investors are cautioned that these statements are not guarantees of future performance. Actual results may differ materially from the forward-looking statements as a result of a number of risks and uncertainties, many of which are difficult to predict and generally beyond the control of Holcim, including but not limited to the risks described in the Holcim's annual report available on its website (www.holcim.com) and uncertainties related to the market conditions and the implementation of our plans. Accordingly, we caution you against relying on forward-looking statements. Holcim does not undertake to provide updates of these forward-looking statements.



End of Media Release
View original content: EQS News


2223638  04.11.2025 CET/CEST

Analysen zu Holcim AG

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
07.11.25 Holcim Outperform Bernstein Research
04.09.25 Holcim Buy Goldman Sachs Group Inc.
30.06.25 Holcim Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
10.06.25 Holcim Overweight Barclays Capital
20.11.24 Holcim Overweight JP Morgan Chase & Co.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest

Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.

Schnell noch Plätze sichern!

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’078.08 19.16 U5BSSU
Short 13’346.51 13.54 B6CSKU
Short 13’811.57 8.96 SI9BRU
SMI-Kurs: 12’549.51 11.11.2025 09:52:29
Long 12’024.85 19.46 SZ8B6U
Long 11’779.56 13.99 SIXBJU
Long 11’271.58 8.93 SJ9BIU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

Holcim AG 71.92 0.73% Holcim AG

Holcim am 04.11.2025

Chart